康缘药业：公司积极服务于人口老龄化国家宏观经济战略

Core Viewpoint - Kangyuan Pharmaceutical has initiated clinical trials for Longqi Capsules in response to supplementary material requirements and will disclose key information regarding trial progress and review results in accordance with legal regulations [1] Group 1: Company Initiatives - The company is actively aligning with the macroeconomic strategy of an aging population, leveraging its strengths in traditional Chinese medicine to address health needs of the elderly [1] - Kangyuan Pharmaceutical has core products targeting age-related diseases, including Ginkgo Biloba Diterpene Injection, Tienshu Capsules/Tablets, and Tongsemai Capsules/Tablets [1] Group 2: Research and Development Focus - The company is expanding its research and development efforts in areas related to aging, including Alzheimer's disease, sleep disorders, and chronic obstructive pulmonary disease, with relevant products already in clinical stages [1]